Identification of active transcription factor and miRNA regulatory pathways in Alzheimer's disease.
about
An Emerging Role of micro-RNA in the Effect of the Endocrine DisruptorsDiagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-AnalysisUp-Regulation of miRNA-146a in Progressive, Age-Related Inflammatory Neurodegenerative Disorders of the Human CNSMicroRNAs as potential signatures of environmental exposure or effect: a systematic reviewImproved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data.Microglia change from a reactive to an age-like phenotype with the time in cultureA functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients.Clinically relevant genes and regulatory pathways associated with NRASQ61 mutations in melanoma through an integrative genomics approach.A novel motif-discovery algorithm to identify co-regulatory motifs in large transcription factor and microRNA co-regulatory networks in human.Identification of active miRNA and transcription factor regulatory pathways in human obesity-related inflammationUnraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue SarcomaTMREC: A Database of Transcription Factor and MiRNA Regulatory Cascades in Human Diseases.MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer's Disease (AD)-Novel and Unique Pathological FeaturesMicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's diseaseDecreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.ROCK1 Is Associated with Alzheimer's Disease-Specific Plaques, as well as Enhances Autophagosome Formation But not Autophagic Aβ Clearance.Polyethyleneimine-coated quantum dots for miRNA delivery and its enhanced suppression in HepG2 cellsMicroRNA regulatory pathway analysis identifies miR-142-5p as a negative regulator of TGF-β pathway via targeting SMAD3.From miRNA regulation to miRNA-TF co-regulation: computational approaches and challenges.Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression DataPathogenic microRNAs Common to Brain and Retinal Degeneration; Recent Observations in Alzheimer's Disease and Age-Related Macular Degeneration.SPARC overexpression alters microRNA expression profiles involved in tumor progressionIntegrated systems approach identifies risk regulatory pathways and key regulators in coronary artery disease.Differential Expression of MicroRNAs in Leprosy Skin Lesions.Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's diseasencPred: ncRNA-Disease Association Prediction through Tripartite Network-Based Inference.BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways.GED: a manually curated comprehensive resource for epigenetic modification of gametogenesis.Analysis of microRNA and Gene Expression Profiles in Alzheimer's Disease: A Meta-Analysis Approach.
P2860
Q26738430-9309FFE3-2CD6-4B88-8677-4B481364FA79Q26768181-FF4B1FC9-F1A8-4C37-B747-26BDFE2E9625Q26851364-3A6AD346-5AFE-401A-910F-F1B1369B69D2Q28393390-69110641-860E-407F-9D58-848F5F720C1FQ31150011-D373D574-192D-47DF-9209-195674EADE0FQ33695687-327CA8EF-FAAF-42D1-A214-8F5B528456BFQ35106556-BE03C6B7-398B-42A9-8BEA-BB2C96FC9749Q35273776-D70140E7-2EBC-4488-BE9F-486880B6DE19Q35581027-C9D216C3-5F0A-4E83-8B7B-16A42F440721Q35607728-86BBC0F3-9ECE-448B-AB1D-4C20009BCB29Q35616920-370AD57B-FB86-4A5C-929E-DBBB0AEF5811Q35620022-DF82F98D-FBD0-42DD-91DA-930CD193A721Q36404334-A433A9AB-045C-4A99-BE5D-1622D8906818Q36934113-9502373C-4767-4C14-A454-6300F9DCAB4DQ37013250-ECA0B873-0315-4852-AD3F-F74DAA747994Q37385622-FEEF35AC-5E21-4C11-B321-F0318970105DQ37426859-05118953-E195-4121-B70C-D7384781617FQ37687648-22D9F539-1863-403F-B4BD-03F17F82C62FQ38228678-67488E91-9C75-491E-888B-3CD1AEB7364AQ38628811-A8694688-66CD-40CC-9F8F-81064E42E952Q38636825-459FAC4A-BABA-42DF-A1FB-FA096FA35895Q38823959-71D6E213-027C-448A-B5F2-F4EED1641F33Q40699459-7983D95E-2BA0-432A-A9E3-B1CEF396B2CBQ41991878-89FC3D22-1895-4301-9E0A-D3BD4E7ED7BDQ42134488-989DD7E4-DC28-49DF-AC8E-1E23E192F2A8Q42586956-49D06ACA-82AC-49DB-8A18-33F1B306A525Q45068656-B0960A9A-A8DB-4111-95C6-80DE092103DFQ46599629-712B6093-3E1A-46D3-814B-A28FCFE471D3Q55253189-51917D4B-75AB-4065-BC32-82E874061313
P2860
Identification of active transcription factor and miRNA regulatory pathways in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Identification of active trans ...... thways in Alzheimer's disease.
@en
type
label
Identification of active trans ...... thways in Alzheimer's disease.
@en
prefLabel
Identification of active trans ...... thways in Alzheimer's disease.
@en
P2093
P2860
P356
P1433
P1476
Identification of active trans ...... thways in Alzheimer's disease.
@en
P2093
Baofeng Lian
Fanlin Meng
Lihong Wang
Shuyuan Wang
Xiaowen Chen
P2860
P304
P356
10.1093/BIOINFORMATICS/BTT423
P407
P577
2013-08-29T00:00:00Z